Feasibility and Surgical Outcomes of Laparoscopic Metastasectomy in the Treatment of Ovarian Metastases From Gastric Cancer
Open accessAbstract
Objectives This study aimed to evaluate the feasibility of laparoscopic metastasectomy (LM) in the treatment of ovarian metastases from gastric cancer and to compare the surgical outcomes with patients who underwent open metastasectomy (OM).Methods The cases of 73 patients who underwent LM (n = 16) or OM (n = 57) were retrospectively reviewed. All patients were diagnosed with gastric cancer and, subsequently, underwent a metastasectomy at Yonsei University Health System between December 2002 and March 2011.Results Sixteen operations were completed laparoscopically with no conversion to laparotomy. Complete cytoreduction surgery was achievable in 13 patients (81.3%). Operating time, complete cytoreduction, and occurrence of perioperative complications were comparable between the 2 groups. The LM group had less blood loss (25 vs 400 mL, P < 0.0001), earlier return to a general diet (3 vs 4 days, P = 0.005), shorter postoperative hospital stay (4.5 vs 7 days, P < 0.0001), and lower postoperative pain scores after 6, 24, and 48 hours than those in the OM group. There were no operative complications in the LM group.Conclusions As a surgical treatment for ovarian metastases from gastric cancer, LM is feasible and provides benefits to patients without detrimental effects on the clinical outcomes for selected patients.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The reduced risk of cancer and cancer mortality observed in studies of metformin users has been consistently in the range of 25% to 30%.
“The reduced risk of cancer and cancer mortality observed in these studies has been consistently in the range of 25% to 30% [135-139,145-147].”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [139]
Patients with type 2 diabetes who are prescribed metformin had a lower risk of cancer compared to patients who did not take it.
“Patients with type 2 diabetes who are prescribed metformin had a lower risk of cancer compared to patients who did not take it.”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [139]
Diabetic patients with colorectal cancer who were treated with metformin had lower mortality than those not receiving metformin.
“Diabetic patients with colorectal cancer who were treated with metformin had lower mortality than those not receiving metformin [139].”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Lacy, A. M., García‐Valdecasas, J. C., Delgado, S., Castells, A., Taurá, P., Piqué, J. M., & Visa, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09290-5 · Cited by 2,441 · see citing works
Walker, J. L., Piedmonte, M. R., Spirtos, N. M., Eisenkop, S. M., Schlaerth, J. B., Mannel, R. S., Spiegel, G., Barakat, R., Pearl, M. L., & Sharma, S. K. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3248 · Cited by 1,288 · see citing works
The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries
Ayhan, A., Güvenal, T., Salman, M. C., et al. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.05.028 · Cited by 137 · see citing works
Secondary Ovarian Malignancies: Frequency, Origin, and Characteristics
de Waal, Y. R. P., Thomas, C. M. G., Oei, A. L. M., et al. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181b33cce · Cited by 136 · see citing works
Two-port versus four-port laparoscopic cholecystectomy
Poon, C. M., Chan, K. W., Lee, D. W. H., et al. (2003) · Surgical Endoscopy · doi:10.1007/s00464-002-8718-9 · Cited by 117 · see citing works
Clinicopathologic features and treatment of postirradiation sarcoma of bone and soft tissue
Inoue, Y., Frassica, F. J., Sim, F. H., Unni, K. K., Petersen, I. A., & McLeod, R. A. (2000) · Journal of Surgical Oncology · doi:10.1002/1096-9098(200009)75:1 · Cited by 98 · see citing works
Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer
Cheong, J., Hyung, W. J., Chen, J., et al. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.05.007 · Cited by 91 · see citing works
Minimizing ancillary ports size in gynecologic laparoscopy: A randomized trial
Ghezzi, F., Cromi, A., Colombo, G., et al. (2005) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2005.09.002 · Cited by 76 · see citing works
Krukenberg tumor of the ovaries. A review of 81 records.
Hale, R. W. (1968) · PubMed · Cited by 69 · see citing works
Kjærbye‐Thygesen, A., Huusom, L. D., Frederiksen, K., et al. (2005) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.0001-6349.2005.00878.x · Cited by 41 · see citing works
Laparoscopy compared with laparotomy for the surgical staging of endometrial carcinoma
Chung Kit, W. O. N. G., Wong, Y. H., Lo, L. S. F., et al. (2005) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2005.00289.x · Cited by 38 · see citing works
Clinical Aspects of Metastatic Ovarian Cancer of Extragenital Origin
Johansson, H. F. (1960) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016346009155745 · Cited by 34 · see citing works
Ewing's sarcoma in female siblings: A clinical report and review of the literature
Joyce, M., Harmon, D. C., Mankin, H. J., Suit, H. D., Schiller, A. L., & Truman, J. T. (1984) · Cancer · doi:10.1002/1097-0142(19840501)53:9 · Cited by 32 · see citing works
Song, M., Nio, Y., Dong, M., Tamura, K., Furuse, K., Tian, Y., He, S.-G., & Shen, K. (2000) · Journal of Surgical Oncology · doi:10.1002/1096-9098(200011)75:3 · Cited by 30 · see citing works
Ovarian involvement in extragenital cancer
Roberto Yazigi, I., & Sandstad, J. (1989) · Gynecologic Oncology · doi:10.1016/0090-8258(89)90113-3 · Cited by 30 · see citing works
McCormick, T. C., Muffly, T. M., Lu, G., et al. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181a83ea2 · Cited by 27 · see citing works
Nongenital metastatic cancers of the ovary: a clinical analysis.
Akhan, S. E., Kilic, G., Salihoğlu, M. Y., et al. (2001) · PubMed · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Metformin: An Old But Still the Best Treatment for Type 2 Diabetes
Rojas, L. B. A., & Gomes, M. B. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-6 · Cited by 567 · see citing works
- Authors
- Lee, M., Paek, J., Lee, S. H., Yim, G. W., Kim, S. W., Kim, S., Kim, J. H., Kim, Y. T., & Nam, E. J.
- Affiliations
- Yonsei University (KR)
- Corresponding author
- Nam, Eun Ji
- ORCID
- Venue
- International Journal of Gynecological Cancer
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 21
- Issue
- 7
- Pages
- 1306-1311
- ISSN
- 1048-891X (ISSN-L)
- OpenAlex
- W2102766511
- Cited by
- 4
- References
- 17
- Citations by year
- 2024: 1 · 2018: 1 · 2013: 2
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- International Journal of Gynecological Cancer (publishedVersion)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- AJOU Open Repository (Ajou University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Gastric Cancer Management and Outcomes
- Keywords
- ovarian metastasis, gastric cancer, complete cytoreduction, surgical outcomes, perioperative complications, postoperative pain, blood loss, length of hospital stay
- MeSH terms
- Adenocarcinoma, Adult, Feasibility Studies, Female, Humans, Middle Aged, Neoplasm Metastasis, Ovarian Neoplasms, Laparoscopy, Stomach Neoplasms, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
